CDE stock news

CDE stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.

See the full wire

20 wire items

2026-10-29 00:25:00 UTC#533532newconfirmednews

Junshi Biosciences' supplemental NDA for toripalimab subcutaneous injection in HER2+ urothelial carcinoma accepted by NMPA

globenewswireimportance 0.40trust 0.90Shanghai Junshi Biosciences Co., Ltd. +0.40Toripalimab +0.40Disitamab vedotin +0.30+2 entities

2026-10-28 14:51:44 UTC#529841newconfirmednews

Shanghai Junshi Biosciences receives NMPA approval for Toripalimab as monotherapy for advanced urothelial carcinoma

reutersimportance 0.50trust 0.90Shanghai Junshi Biosciences Co., Ltd. +0.60National Medical Products Administration +0.60

2026-10-27 17:13:34 UTC#523022newconfirmednews

Ocumension Therapeutics receives NMPA approval for localized production of Fluocinolone Acetonide Intravitreal Implant

reutersimportance 0.40trust 0.90Ocumension Therapeutics +0.60National Medical Products Administration +0.20Fluocinolone Acetonide Intravitreal Implant +0.60

2026-10-27 10:22:27 UTC#520100newconfirmednews

Livzon Pharmaceutical unit Mabpharm receives NMPA approval for drug clinical trial in China

reutersimportance 0.40trust 0.80Livzon Pharmaceutical Group Inc. +0.30Mabpharm Limited +0.30National Medical Products Administration +0.20+1 entities

2026-10-27 01:43:39 UTC#518245newconfirmednews

Sino Biopharmaceutical drug candidates TQ-A3334 and TQA3605 receive Breakthrough Therapy Designation from CDE

reutersimportance 0.40trust 0.90Sino Biopharmaceutical Limited +0.50TQ-A3334 +0.50TQA3605 +0.50+1 entities

2026-10-26 21:22:30 UTC#517491newconfirmednews

Codeifai Ltd. lists ProtectCode security software on Amazon Web Services Marketplace

financial_juiceimportance 0.30trust 0.60Codeifai Ltd. +0.40Amazon.com, Inc. +0.30Amazon Web Services, Inc. +0.30+1 entities

2026-10-26 11:44:00 UTC#514326duplicateconfirmednews

Bayer receives China approval for Sunharbo, the first global Factor XIa inhibitor for stroke prevention

dow_jonesimportance 0.30trust 0.90Bayer AG +0.60Sunharbo +0.60National Medical Products Administration +0.20+2 entities

2026-10-26 10:03:27 UTC#513781duplicateconfirmednews

Bayer receives China regulatory approval for blood thinner asundexian

reutersimportance 0.30trust 0.90Bayer AG +0.50asundexian +0.50National Medical Products Administration +0.20+2 entities

2026-10-26 09:18:00 UTC#513533newconfirmedpress release

Innovent Biologics announces NMPA acceptance of new indication application for Sintilimab in advanced melanoma

pr newswireimportance 0.40trust 0.90Innovent Biologics, Inc. +0.40Sintilimab +0.40National Medical Products Administration +0.30+1 entities

2026-10-26 08:58:00 UTC#513455duplicateconfirmednews

Bayer receives first global approval for Factor XIa inhibitor Sunharbo in China

dow_jonesimportance 0.40trust 0.90Bayer AG +0.60National Medical Products Administration +0.50Sunharbo +0.60+1 entities

2026-10-26 08:43:00 UTC#513398duplicateconfirmednews

Bayer receives China approval for Sunharbo, the first global Factor XIa inhibitor for stroke prevention

dow_jonesimportance 0.40trust 0.90Bayer AG +0.60National Medical Products Administration +0.50Sunharbo +0.60+1 entities

2026-10-23 05:00:16 UTC#504265duplicateconfirmednews

Galderma receives China NMPA approval for Relfydess liquid neuromodulator to treat frown lines

financial postimportance 0.40trust 0.80Galderma Group AG +0.60Relfydess +0.60National Medical Products Administration +0.40+1 entities

2026-10-23 05:00:00 UTC#504263newconfirmednews

Galderma receives China NMPA approval for Relfydess to treat moderate-to-severe frown lines

tradingviewimportance 0.50trust 0.80Galderma Group AG +0.60National Medical Products Administration +0.20Relfydess +0.60+1 entities

2026-10-23 01:35:35 UTC#503802duplicateconfirmednews

HBM Holdings receives NMPA approval for Batoclimab injection to treat generalized myasthenia gravis

reutersimportance 0.40trust 0.90HBM Holdings Ltd +0.60Batoclimab +0.60National Medical Products Administration +0.20+1 entities

2026-10-23 01:21:44 UTC#503772newconfirmednews

CSPC Pharmaceutical receives NMPA drug registration certificate for Batoclimab (Enlida) injection

reutersimportance 0.50trust 0.90CSPC Pharmaceutical Group Limited +0.60Batoclimab +0.60National Medical Products Administration +0.50

2026-10-21 13:17:00 UTC#493320duplicateconfirmedpress release

ProBio Inc. completes NMPA pre-approval inspection for Nanjing biologics facility

pr_newswireimportance 0.30trust 0.90ProBio Inc. +0.40National Medical Products Administration +0.40Nanjing 0+1 entities

2026-10-21 13:17:00 UTC#493319newconfirmednews

ProBio Inc. completes NMPA pre-approval inspection at Nanjing biologics facility

tradingviewimportance 0.40trust 0.70ProBio Inc. +0.40National Medical Products Administration +0.40

2026-10-20 17:43:23 UTC#488101newconfirmednews

LifeTech Scientific's ICS Elpis medical device admitted to NMPA special examination

reutersimportance 0.40trust 0.80LifeTech Scientific Corporation +0.40National Medical Products Administration +0.30ICS Elpis +0.40

2026-10-19 11:16:00 UTC#479918newconfirmedpress release

OncoC4 receives NMPA acceptance for two IND applications to test Cesalatamig in combination with ADCs and Pan-RAS inhibitors

pr newswireimportance 0.40trust 0.90OncoC4 Inc. +0.40Cesalatamig +0.40National Medical Products Administration +0.30+2 entities

2026-10-19 10:26:34 UTC#479625newconfirmedpress release

Shandong Xinhua Pharmaceutical Nimodipine tablets receive NMPA generics consistency evaluation approval

reutersimportance 0.30trust 0.90Shandong Xinhua Pharmaceutical Co., Ltd. +0.30National Medical Products Administration +0.20Nimodipine +0.30